You are viewing: Rest Of Europe Endoscopic Submucosal Dissection/ESD Market analysis

The Rest Of Europe Endoscopic Submucosal Dissection/ESD Market was valued at $25.8 Million in 2025 and projected to reach to $41.6 Million by 2030, representing a compound annual growth rate of 10.0%. Rest Of Europe's ESD market is positioned for sustained growth through 2030, driven by healthcare system modernization and increasing investment in advanced endoscopic capabilities.

Rest Of Europe Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • Rest Of Europe's market is expanding at a compound annual growth rate (CAGR) of 10.0%, driven by increasing adoption of minimally invasive gastrointestinal procedures and rising prevalence of early-stage cancers.
  • Rest Of Europe benefits from advancing healthcare infrastructure, growing physician training in ESD techniques, and heightened patient awareness of endoscopic treatment options. Rest Of Europe's ESD market growth is supported by favorable reimbursement policies across multiple countries and the introduction of innovative endoscopic devices.
  • Rest Of Europe continues to witness strong demand for tissue resection and therapeutic interventions, particularly in colorectal and gastric applications.
  • The region's market trajectory reflects broader European trends toward precision medicine and organ-preserving treatment modalities, positioning Rest Of Europe as a significant contributor to the continental ESD market expansion through 2030..

Key Market Statistics

  • CAGR (2025-2030) 10.0% CAGR
  • Market Size, 2025 ~USD 25.8 Million
  • Forecast, 2030 ~USD 41.6 Million
  • Country Rest Of Europe

Rest Of Europe Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation Growth :

Rest Of Europe's ESD market is valued at USD 25.8 million in 2025, with strong expansion projected to USD 41.6 million by 2030, representing a 61% increase over the forecast period.

Regional CAGR Performance :

Rest Of Europe demonstrates a 10% CAGR through 2030, outpacing the global market growth rate of 8.4%, indicating accelerated adoption of minimally invasive endoscopic procedures in the region.

Minimally Invasive Procedure Adoption :

Increasing preference for ESD over traditional surgical interventions in Rest Of Europe is driven by patient demand for reduced recovery times, lower morbidity rates, and improved quality of life outcomes.

Early-Stage Cancer Detection :

Rising prevalence of early-stage gastrointestinal cancers across Rest Of Europe, combined with improved screening programs, is creating sustained demand for advanced endoscopic dissection technologies and expertise.

Rest Of Europe Endoscopic Submucosal Dissection/ESD Market Dynamics

  • The region's aging population and rising cancer incidence rates are propelling adoption of minimally invasive treatment options.
  • Healthcare providers across Rest Of Europe are expanding their endoscopy departments and training specialized personnel to meet growing patient demand. Regulatory support for innovative medical devices and reimbursement improvements are facilitating market expansion.
  • The competitive landscape is intensifying as both established medical device manufacturers and emerging players establish regional presence.
  • Strategic partnerships between hospitals and device suppliers are accelerating technology adoption, positioning Rest Of Europe as a high-growth market within the broader European ESD landscape..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Rest Of Europe's ESD market is valued at USD 25.8 million in 2025 and is forecast to reach USD 41.6 million by 2030, representing a 10.0% CAGR.
    • Rest Of Europe is experiencing accelerating adoption of minimally invasive endoscopic procedures driven by improved clinical outcomes and patient preference for organ-preserving treatments.
    • Rest Of Europe's market growth is supported by enhanced reimbursement frameworks, increased physician expertise, and expanding availability of advanced ESD devices across the region.
    • Rest Of Europe's ESD market is positioned as a key growth engine within Europe, with strong demand for therapeutic gastrointestinal interventions in colorectal and gastric indications.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    Rest Of Europe Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ESD device and accessory manufacturers need Rest Of Europe-specific market data to guide product development, pricing strategies, regulatory submissions, and sales force allocation across the region's diverse healthcare systems.
    • Healthcare Providers & Hospital Networks : Hospital administrators and gastroenterology departments require market insights to justify capital investments in ESD equipment, plan endoscopy center expansion, and benchmark their adoption rates against regional competitors.
    • Private Equity & Investment Firms : Investors evaluating healthcare acquisitions and expansion opportunities in Rest Of Europe need detailed market sizing and growth projections to assess portfolio company potential and identify consolidation targets.
    • Healthcare Consultants & Strategy Firms : Management consultants advising healthcare organizations and medical device companies require Rest Of Europe-specific market data to develop regional strategies, competitive analyses, and market entry recommendations.
    • Regulatory & Reimbursement Specialists : Professionals navigating Rest Of Europe's fragmented regulatory and reimbursement landscape need market intelligence to understand regional healthcare policies, pricing pressures, and coverage decisions affecting ESD adoption.

    Key Companies in the Rest Of Europe Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to Rest Of Europe, including 2025 baseline (USD 25.8M) and 2030 projections (USD 41.6M), enabling accurate budget allocation and revenue forecasting for regional operations.
    • Competitive Landscape Intelligence : Understand Rest Of Europe's competitive dynamics, market consolidation trends, and key player strategies tailored to regional healthcare systems, reimbursement structures, and regulatory environments.
    • Growth Driver Analysis : Identify region-specific growth catalysts including aging demographics, cancer prevalence rates, healthcare infrastructure investments, and adoption barriers unique to Rest Of Europe's diverse healthcare markets.
    • Strategic Market Entry Planning : Develop targeted go-to-market strategies for Rest Of Europe by understanding regional hospital networks, physician preferences, reimbursement pathways, and distribution channel requirements specific to non-major European markets.
    • Investment & Partnership Opportunities : Identify high-potential acquisition targets, partnership opportunities, and expansion markets within Rest Of Europe based on market growth rates, healthcare spending trends, and technology adoption readiness.

    Frequently asked questions

    What is the current market size of ESD in Rest Of Europe?

    Rest Of Europe's ESD market is valued at USD 25.8 million in 2025 and is expected to grow to USD 41.6 million by 2030.

    What is the projected growth rate for Rest Of Europe's ESD market?

    Rest Of Europe's ESD market is projected to grow at a compound annual growth rate (CAGR) of 10.0% from 2025 to 2030.

    What factors are driving ESD market growth in Rest Of Europe?

    Rest Of Europe's ESD market growth is driven by increasing adoption of minimally invasive procedures, rising early-stage cancer prevalence, improved reimbursement policies, and growing physician expertise in endoscopic techniques.

    Which clinical applications are most prominent in Rest Of Europe's ESD market?

    Rest Of Europe shows strong demand for ESD in colorectal and gastric applications, reflecting the region's focus on organ-preserving therapeutic interventions.

    How does Rest Of Europe's ESD market compare to global trends?

    Rest Of Europe's ESD market CAGR of 10.0% exceeds the global CAGR of 8.4%, indicating faster regional adoption and market expansion relative to worldwide trends.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status